Metabolic Profile and Anthropometric Changes in Schizophrenia
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
"No clinical differences will be found between the three antipsychotics under study -
olanzapine, risperidone and haloperidol - on the patients' metabolic profile and weight. "